Viking Therapeutics (VKTX) Treasury Shares (2014 - 2026)

Viking Therapeutics has disclosed Treasury Shares across 13 years of filings, most recently posting $30211.0 for Q1 2026.

• Treasury Shares for Q4 2023 came in at $6.8 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2023 was $6.8 million (changed 0.0% YoY), and the FY2023 annual result was $6.8 million, changed 0.0% from the prior year.
• Treasury Shares came in at $6.8 million for Q4 2023 at Viking Therapeutics, roughly flat from $6.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $6.8 million in Q2 2022 to a low of $5.1 million in Q1 2022.
• The 5-year median for Treasury Shares is $2.0 million (2022), against an average of $1.7 million.
• Across the five-year window, Treasury Shares surged 1155.25% in 2025 and sank 98.69% in 2026, its largest moves.
• Viking Therapeutics' Treasury Shares stood at $6.8 million in 2022, then changed by 0.0% to $6.8 million in 2023.
• The last three Treasury Shares figures came in at $6.8 million (Q4 2023), $6.8 million (Q3 2023), and $6.8 million (Q2 2023), per Business Quant data.